ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: Discrimination of critical variants using a gene-wide haplotype tagging approach

Human Molecular Genetics

Volumn 15, Issue 5, 2006, Pages 797-805

  Ho, G T ^a,b   Soranzo, N ^c   Nimmo, E R ^a   Tenesa, A ^b   Goldstein, D B ^c   Satsangi, J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1;

ADULT; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; EPILEPSY; FEMALE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRON; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENES, MDR; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTRONS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS);

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33144478521     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddi494     Document Type: Article

References (50)

1. Podolsky, D.K. (2002) Inflammatory bowel disease. N. Engl. J. Med., 347, 417-429.
2. Colombel, J.F., Tamboli, C.P. and Hugot, J.P. (2003) Clinical Genetics of Inflammatory Bowel Diseases: Genetic Epidemiology, Genotype/Phenotype and Pharmacogenetics: Inflammatory Bowel Diseases. Saunders, Philadelphia.
3. Bonen, D.K. and Cho, J.H. (2003) The genetics of inflammatory bowel disease. Gastroenterology, 124, 521-536.
4. Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R.H. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411, 603-606.
5. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411, 599-603.
6. Stoll, M., Corneliussen, B., Costello, C.M., Waetzig, G.H., Mellgard, B., Koch, W.A., Rosenstiel, P., Albrecht, M., Croucher, P.J., Seegert, D. et al. (2004) Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat. Genet., 36, 476-480.
7. Peltekova, V.D., Wintle, R.F., Rubin, L.A., Amos, C.I., Huang, Q., Gu, X., Newman, B., Van Oene, M., Cescon, D., Greenberg, G. et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet., 36, 471-475.
8. Mcgovern, D.P., Hysi, P., Ahmad, T., Van Heel, D.A., Moffatt, M.F., Carey, A., Cookson, W.O. and Jewell, D.P. (2005) Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum. Mol. Genet., 14, 1245-1250.
9. Ho, G.T., Moodie, F.M. and Satsangi, J. (2003) Multidrug resistance 1 gene (P-glycoprotein 170): An important determinant in gastrointestinal disease? Gut, 52, 759-766.
10. Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M.M., Pastan, I. and Willingham, M.C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl Acad. Sci. USA, 84, 7735-7738.
11. Cordon-Cardo, C., O'Brien, J.P., Casals, D., Rittman-Grauer, L., Biedler, J.L., Melamed, M.R. and Bertino, J.R. (1989) Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc. Natl Acad. Sci. USA, 86, 695-698.
12. Fojo, A.T., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M. and Pastan, I. (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl Acad. Sci. USA, 84, 265-269.
13. Panwala, C.M., Jones, J.C. and Viney, J.L. (1998) A novel model of inflammatory bowel disease: Mice deficient for the multiple drug resistance gene, Mdr1a, spontaneously develop colitis. J. Immunol., 161, 5733-5744.
14. Langmann, T., Moehle, C., Mauerer, R., Scharl, M., Liebisch, G., Zahn, A., Stremmel, W. and Schmitz, G. (2004) Loss of detoxification in inflammatory bowel disease: Dysregulation of pregnane X receptor target genes. Gastroenterology, 127, 26-40.
15. Hoffmeyer, S., Burk, O., Von Richter, O., Arnold, H.P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M. and Brinkmann, U. (2000) Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl Acad. Sci. USA, 97, 3473-3478.
16. Hitzl, M., Drescher, S., Van Der Kuip, H., Schaffeler, E., Fischer, J., Schwab, M., Eichelbaum, M. and Fromm, M.F. (2001) The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics, 11, 293-298.
17. Kim, R.B., Leake, B.F., Choo, E.F., Dresser, G.K., Kubba, S.V., Schwarz, U.I., Taylor, A., Xie, H.G., Mckinsey, J., Zhou, S. et al. (2001) Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin. Pharmacol. Ther., 70, 189-199.
18. Johne, A., Kopke, K., Gerloff, T., Mai, I., Rietbrock, S., Meisel, C., Hoffmeyer, S., Kerb, R., Fromm, M.F., Brinkmann, U. et al. (2002) Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene. Clin. Pharmacol. Ther., 72, 584-594.
19. Tanabe, M., Ieiri, I., Nagata, N., Inoue, K., Ito, S., Kanamori, Y., Takahashi, M., Kurata, Y., Kigawa, J., Higuchi, S., Terakawa, N. and Otsubo, K. (2001) Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J. Pharmacol. Exp. Ther., 297, 1137-1143.
20. Morita, N., Yasumori, T. and Nakayama, K. (2003) Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities. Biochem. Pharmacol., 65, 1843-1852.
21. Nakamura, T., Sakaeda, T., Horinouchi, M., Tamura, T., Aoyama, N., Shirakawa, T., Matsuo, M., Kasuga, M. and Okumura, K. (2002) Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin. Pharmacol. Ther., 71, 297-303.
22. Drescher, S., Schaeffeler, E., Hitzl, M., Hofmann, U., Schwab, M., Brinkmann, U., Eichelbaum, M. and Fromm, M.F. (2002) MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br. J. Clin. Pharmacol., 53, 526-534.
23. Sakaeda, T., Nakamura, T., Horinouchi, M., Kakumoto, M., Ohmoto, N., Sakai, T., Morita, Y., Tamura, T., Aoyama, N., Hirai, M., Kasuga, M. and Okumura, K. (2001) MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm. Res., 18, 1400-1404.
24. Soranzo, N., Cavalleri, G.L., Weale, M.E., Wood, N.W., Depondt, C., Marguerie, R., Sisodiya, S.M. and Goldstein, D.B. (2004) Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene. Genome Res., 14, 1333-1344.
25. Schwab, M., Schaeffeler, E., Marx, C., Fromm, M.F., Kaskas, B., Metzler, J., Stange, E., Herfarth, H., Schoelmerich, J., Gregor, M. et al. (2003) Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology, 124, 26-33.
26. Brant, S.R., Panhuysen, C.I., Nicolae, D., Reddy, D.M., Bonen, D.K., Karaliukas, R., Zhang, L., Swanson, E., Datta, L.W., Moran, T et al. (2003) MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am. J. Hum. Genet., 73, 1282-1292.
27. Croucher, P.J., Mascheretti, S., Foelsch, U.R., Hampe, J. and Schreiber, S. (2003) Lack of association between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations. Gastroenterology, 125, 1919-1920.
28. Glas, J., Torok, H.P., Schiemann, U. and Folwaczny, C. (2004) MDR1 gene polymorphism in ulcerative colitis. Gastroenterology, 126, 367.
29. Potocnik, U., Ferkolj, I., Glavac, D. and Dean, M. (2004) Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis. Genes Immun., 5, 530-539.
30. Ho, G.T., Nimmo, E.R., Tenesa, A., Fennell, J., Drummond, H., Mowat, C., Arnott, I.D. and Satsangi, J. (2005) Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology, 128, 288-296.
31. Weale, M.E., Depondt, C., Macdonald, S.J., Smith, A., Lai, P.S., Shorvon, S.D., Wood, N.W. and Goldstein, D.B. (2003) Selection and evaluation of tagging snps in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. Am. J. Hum. Genet., 73, 551-565.
32. Goldstein, D.B., Ahmadi, K.R., Weale, M.E. and Wood, N.W. (2003) Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet., 19, 615-622.
33. Neale, B.M. and Sham, P.C. (2004) The future of association studies: gene-based analysis and replication. Am. J. Hum. Genet., 75, 353-362.
34. Newman, B., Gu, X., Wintle, R., Cescon, D., Yazdanpanah, M., Liu, X., Peltekova, V., Van Oene, M., Amos, C.I. and Siminovitch, K.A. (2005) A risk haplotype in the solute carrier family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. Gastroenterology, 128, 260-269.
35. Hampe, J., Cuthbert, A., Croucher, P.J., Mirza, M.M., Mascheretti, S., Fisher, S., Frenzel, H., King, K., Hasselmeyer, A., Macpherson, A.J. et al. (2001) Association between insertion mutation in NOD2 gene and Crohn's disease in german and british populations. Lancet, 357, 1925-1928.
36. Van Eerdewegh, P., Little, R.D., Dupuis, J., Del Mastro, R.G., Falls, K., Simon, J., Torrey, D., Pandit, S., McKenny, J., Braunschweiger, K. et al. (2002) Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature, 418, 426-430.
37. Ahmad, T., Armuzzi, A., Bunce, M., Mulcahy-Hawes, K., Marshall, S.E., Orchard, T.R., Crawshaw, J., Large, O., de Silva, A., Cook, J.T. et al. (2002) The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology, 122, 854-866.
38. Cuthbert, A.P., Fisher, S.A., Mirza, M.M., King, K., Hampe, J., Croucher, P.J., Mascheretti, S., Sanderson, J., Forbes, A., Mansfield, J. et al. (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology, 122, 867-874.
39. Lesage, S., Zouali, H., Cezard, J.P., Colombel, J.F., Belaiche, J., Almer, S., Tysk, C., O'Morain, C., Gassull, M., Binder, V. et al. (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet., 70, 845-857.
40. Rioux, J.D., Daly, M.J., Silverberg, M.S., Lindblad, K., Steinhart, H., Cohen, Z., Delmonte, T., Kocher, K., Miller, K., Guschwan, S., Kulbokas, E.J. et al. (2001) Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet., 29, 223-228.
41. Valentonyte, R., Hampe, J., Huse, K., Rosenstiel, P., Albrecht, M., Stenzel, A., Nagy, M., Gaede, K.I., Franke, A., Haesler, R. et al. (2005) Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet., 37, 357-364.
42. Healy, D.G., Abou-Sleiman, P.M., Quinn, N., Ahmadi, K.R., Ozawa, T., Kamm, C., Wullner, U., Oertel, W.H., Burk, K., Dupont, E. et al. (2005) UCHL-1 gene in multiple system atrophy: A haplotype tagging approach. mov. Disord., 20, 1338-1343.
43. Ahmadi, K.R., Weale, M.E., Xue, Z.Y., Soranzo, N., Yarnall, D.P., Briley, J.D., Maruyama, Y., Kobayashi, M., Wood, N.W., Spurr, N.K. et al. (2005) A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nat. Genet., 37, 84-89.
44. Kamatani, N., Sekine, A., Kitamoto, T., Iida, A., Saito, S., Kogame, A., Inoue, E., Kawamoto, M., Harigai, M. and Nakamura, Y. (2004) Large-scale single-nucleotide polymorphism (SNP) and haplotype analyses, using dense snp maps, of 199 drug-related genes in 752 subjects: The analysis of the association between uncommon SNPs within haplotype blocks and the haplotypes constructed with haplotype-tagging SNPs. Am. J. Hum. Genet., 75, 190-203.
45. Siddiqui, A., Kerb, R., Weale, M.E., Brinkmann, U., Smith, A., Goldstein, D.B., Wood, N.W. and Sisodiya, S.M. (2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N. Engl. J. Med., 348, 1442-1448.
46. Fellay, J., Marzolini, C., Meaden, E.R., Back, D.J., Buclin, T., Chave, J.P., Decosterd, L.A., Furrer, H., Opravil, M., Pantaleo, G. et al. (2002) Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: A pharmacogenetics study. Lancet, 359, 30-36.
47. Siegsmund, M., Brinkmann, U., Schaffeler, E., Weirich, G., Schwab, M., Eichelbaum, M., Fritz, P., Burk, O., Decker, J., Alken, P. et al. (2002) Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J. Am. Soc. Nephrol., 13, 1847-1854.
48. Zhao, J.H., Curtis, D. and Sham, P.C. (2000) Model-free analysis and permutation tests for allelic associations. Hum. Hered., 50, 133-139.
49. Qin, Z.S., Niu, T. and Liu, J.S. (2002) Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am. J. Hum. Genet., 71, 1242-1247.
50. Gasche, C., Scholmerich, J., Brynskov, J., D'Haens, G., Hanauer, S.B., Irvine, E.J., Jewell, D.P., Rachmilewitz, D., Sachar, D.B., Sandborn, W.J. and Sutherland, L.R. (2000) A simple classification of Crohn's disease: Report of the Working Party for The World Congresses Of Gastroenterology, Vienna 1998. Inflamm. Bowel Dis., 6, 8-15.